Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Migraine frequency | |||||
Systematic review |
Children aged 18 years and younger with migraine, tension headache, and mixed headaches 2 RCTs in this analysis |
Headaches per month
at 3 months
with flunarizine with placebo |
Mean difference –2.27 95% CI –4.65 to +0.11 P value not reported Reported as a clinically meaningful difference, but sample size in the analysis too small to be statistically significant Heterogeneity: I2 = 85.6% (P value not reported) |
Not significant | |
Systematic review |
Children aged 18 years and younger with migraine Data from 1 RCT |
Headaches per month
at 3 months
with flunarizine with placebo |
Mean difference –3.52 95% CI –4.91 to –2.13 P value not reported |
Effect size not calculated | flunarizine |
Migraine duration | |||||
Systematic review |
48 children aged 18 years or younger with migraine (defined using Vahlquist criteria) Data from 1 RCT |
Mean headache duration per attack (hours)
at 3 months
2.21 with flunarizine 2.76 with placebo |
Standardised mean difference –0.41 95% CI –1.02 to +0.20 Reported as not statistically significant P value not reported |
Not significant |